The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Researchers from The University of Osaka in collaboration with Baylor College of Medicine have developed a new therapy for a ...

Pipeline advancements and investment in innovation and disruptive technologies to help fuel sustainable, profitable growth for CSL's three businesses, CSL Behring, CSL Seqirus and CSL Vifor, in the ...

N of 1 therapy uniquely developed, on demand, for infant with life-threatening rare metabolic disorder in six months Results published in The New England Journal of Medicine and showcased at American ...

The growing demand for gene therapy and mRNA vaccines is driving the need for highly purified plasmid DNA. Manufacturing companies are moving towards 'GMP' standards to meet clinical and commercial ...

COVID-19 mRNA-based vaccines seemingly boosted immunity in cancer patients, significantly prolonging their lives, new ...

Gene therapies are unlocking new drug targets that were previously thought undruggable. Covering modalities like ASOs, siRNA, saRNA, mRNA, and ADARs, each with different mechanisms of action, gene ...

Voyager Therapeutics, Inc. has announced that it will present eight oral and poster presentations at the American Society of Gene & Cell Therapy's upcoming annual meeting, focusing on its innovative ...

Researchers have discovered that the mRNA technology used in COVID-19 vaccines could also help detect and fight cancer ...